Mankind Pharma IPO opened for subscription on 25 April and the issue has been fully subscribed at 2.13 times on day 3, with total bids of 5.98 crore shares for the 2.8 crore shares offered. Qualified institutional buyers (QIBs) subscribed for 573% of their reserved portion, demonstrating high interest in the issue. The portion for […]
